
CP · NYSE
Consensus is Buy, supported by all 28 analysts in the supplied summary, with a mean price target of $101.50. The target range cannot be assessed because both the low and high targets are listed as unavailable; no named analyst or firm is identified as most or least bullish. The supplied evidence also records no rating or target revisions during the past week. Accordingly, it does not establish whether targets are clustering, how wide the dispersion is, or which analysts disagree most. The substantive investment debate visible in the evidence is operational: proponents emphasize CP’s earnings and revenue beats, pricing, volume growth and network efficiency, while skeptics focus on higher fuel costs, the year-over-year profit decline and the stock’s post-release weakness.